| 2-AG | 2-arachidonoylglycerol |
| AEA or anandamide | N-arachidonoylethanolamide |
| ANGPT | angiopoietin |
| APC | antigen-presenting cell |
| B cell | B lymphocyte |
| BAD | BCL2 associated agonist of cell death |
| BMMC | bone-marrow-derived mast cell |
| cAMP | cyclic adenosine monophosphate |
| CB | cannabinoid |
| CBD | cannabidiol |
| Cdk | cyclin-dependent kinase |
| CLL | chronic lymphocytic leukemia |
| CNS | central nervous system |
| COX | cyclooxygenase |
| CSC | cancer stem cells |
| CXCR4 | C-X-C chemokine receptor type 4 |
| DC | dendritic cell |
| EC | endocannabinoid |
| ECS | endocannabinoid system |
| EGF | epidermal growth factor |
| EMT | epithelial–mesenchymal transition |
| ERK | extracellular receptor kinase |
| FAAH | fatty acid amide hydrolase |
| GCS | glioblastoma stem-like cells |
| HGF | hepatocyte growth factor |
| HLM | human lung macrophage |
| IFN | interferon |
| IL | interleukin |
| LPS | lipopolysaccharide |
| MAGL | monoacylglycerol lipase |
| MAPK | mitogen-activated protein kinase |
| MCL | mantle cell lymphoma |
| MCs | mast cells |
| MDM | monocyte-derived macrophage |
| MMP | matrix metalloproteinase |
| NK cell | natural killer cell |
| OEA | oleoylethanolamide |
| pDC | plasmacytoid dendritic cell |
| PEA | palmitoylethanolamide |
| PI3K | phosphoinositide 3-kinase |
| PKB | pro-tumorigenic protein kinase B |
| PIGF | placental growth factor |
| PMN | neutrophil |
| PPAR | peroxisome proliferator-activated receptors |
| ROS | reactive oxygen species |
| SCB | synthetic cannabinoid |
| T cell | T lymphocyte |
| Th cell | T helper cell |
| TIMP | tissue inhibitors of metalloproteinases |
| TLR | toll-like receptor |
| TME | tumor microenvironment |
| TNF | tumor necrosis factor |
| TRB3 | Tribbles homolog 3 |
| TRP | transient receptor potential channels |
| VEGF | vascular endothelial growth factor |
| Δ9-THC | Δ9-tetrahydrocannabinol. |